In terms of cytokine/chemokines release, DSF could reduce expression of inflammatory cytokines and chemokines and reduced CD86 and MHC class II expressions during inflammation, autoimmune diseases, or tumors. The gene discussed is CD86; the disease is autoimmune disease.